Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
3.280
+0.100 (3.14%)
At close: Jul 27, 2026, 4:00 PM EDT
3.350
+0.070 (2.13%)
After-hours: Jul 27, 2026, 5:13 PM EDT

Sana Biotechnology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
9841,0863658077552,863
Market Cap Growth
-15.15%197.43%-54.79%6.99%-73.64%-
Enterprise Value
968.161,026306.69706.16438.832,423
Last Close Price
3.284.071.634.083.9515.48

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
7.206.751.462.811.513.93
P/TBV Ratio
--7.439.052.484.87

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.510.400.330.320.190.14
Net Debt / Equity Ratio
-0.22-0.37-0.23-0.35-0.63-0.60
Net Debt / EBITDA Ratio
0.110.250.230.371.231.27
Net Debt / FCF Ratio
0.190.410.230.371.011.57
Quick Ratio
1.171.763.363.183.805.55
Current Ratio
1.291.893.543.313.995.62
Return on Equity (ROE)
-172.77%-118.70%-99.17%-72.00%-43.90%-61.36%
Return on Assets (ROA)
-62.82%-54.54%-51.15%-42.24%-27.92%-38.38%
Return on Invested Capital (ROIC)
-254.94%-170.54%-144.06%-158.45%-115.48%-172.50%
Return on Capital Employed (ROCE)
-79.39%-63.07%-57.03%-48.37%-31.30%-41.28%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-11.48%-9.68%-18.69%-3.29%-13.17%-1178.88%
Total Shareholder Return
-11.48%-9.68%-18.69%-3.29%-13.17%-1178.88%
SEC Filings: 10-K · 10-Q